• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[从接受齐多夫定治疗的患者中分离出的HIV-1逆转录酶基因的突变]

[Mutations of HIV-1 RT gene isolated from patients treated with AZT].

作者信息

Kondo M, Saito T, Ito A, Oka S, Takata N, Imai M

机构信息

Department of Virology, Kanagawa Prefectural Public Health Laboratories.

出版信息

Kansenshogaku Zasshi. 1993 Mar;67(3):185-9. doi: 10.11150/kansenshogakuzasshi1970.67.185.

DOI:10.11150/kansenshogakuzasshi1970.67.185
PMID:7683706
Abstract

HIV-1 strains were isolated from three patients treated with AZT and from three patients not treated with AZT. Progenomes of HIV-1 RT gene were amplified by PCR and cloned to M13mp18 vecter. Four amino acid mutations in RT gene (Asp67, Lys70, Thr215, Lys219) associated with resistance to AZT were analysed. All of the 14 clones obtained from the three patients with AZT therapy had mutations at codon 215 (Thr-->Tyr or Phe). Some of the 14 clones also had other mutations at codon 67 (Asp-->Asn or Ser), codon 70 (Lys-->Arg) and codon 219 (Lys-->Glu). All of 18 clones obtained from the patients not treated with AZT have no mutation at any codon mentioned above.

摘要

HIV-1毒株分别从三名接受齐多夫定(AZT)治疗的患者和三名未接受AZT治疗的患者中分离得到。通过聚合酶链反应(PCR)扩增HIV-1逆转录酶(RT)基因的前基因组,并克隆到M13mp18载体中。分析了RT基因中与对AZT耐药相关的四个氨基酸突变(Asp67、Lys70、Thr215、Lys219)。从三名接受AZT治疗的患者中获得的14个克隆在密码子215处均发生了突变(Thr→Tyr或Phe)。这14个克隆中的一些在密码子67(Asp→Asn或Ser)、密码子70(Lys→Arg)和密码子219(Lys→Glu)处也有其他突变。从未接受AZT治疗的患者中获得的18个克隆在上述任何密码子处均无突变。

相似文献

1
[Mutations of HIV-1 RT gene isolated from patients treated with AZT].[从接受齐多夫定治疗的患者中分离出的HIV-1逆转录酶基因的突变]
Kansenshogaku Zasshi. 1993 Mar;67(3):185-9. doi: 10.11150/kansenshogakuzasshi1970.67.185.
2
[Reverse transcriptase gene analysis of HIV-1 mutants cultured in the presence of AZT].
Kansenshogaku Zasshi. 1993 Oct;67(10):992-7. doi: 10.11150/kansenshogakuzasshi1970.67.992.
3
Predominance of codon 215 mutation in reverse transcriptase-coding region of 3'-azido-3'-deoxythymidine (AZT)-resistant HIV-1 isolates after long-term AZT therapy.
Kansenshogaku Zasshi. 1995 Nov;69(11):1278-85. doi: 10.11150/kansenshogakuzasshi1970.69.1278.
4
Sequence analysis of proviral HIV RT amplified directly by a semi-quantitative technique from AZT treated patients.通过半定量技术直接从接受齐多夫定治疗的患者中扩增出的前病毒HIV逆转录酶的序列分析。
J Med Virol. 1994 Oct;44(2):115-21. doi: 10.1002/jmv.1890440203.
5
Characterization of HIV isolates arising after prolonged zidovudine therapy.
J Acquir Immune Defic Syndr (1988). 1992;5(8):749-59.
6
Reverse transcriptase sequence of paired isolates of cerebrospinal fluid and blood from patients infected with human immunodeficiency virus type 1 during zidovudine treatment.齐多夫定治疗期间感染1型人类免疫缺陷病毒的患者脑脊液和血液配对分离株的逆转录酶序列
J Clin Microbiol. 1995 Feb;33(2):352-5. doi: 10.1128/jcm.33.2.352-355.1995.
7
Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT).HIV-1逆转录酶中的多个突变赋予对齐多夫定(AZT)的高水平耐药性。
Science. 1989 Dec 1;246(4934):1155-8. doi: 10.1126/science.2479983.
8
Sequence analysis of an HIV-1 isolate which displays unusually high-level AZT resistance in vitro.
J Med Virol. 1992 Feb;36(2):79-83. doi: 10.1002/jmv.1890360204.
9
pol mutations conferring zidovudine and didanosine resistance with different effects in vitro yield multiply resistant human immunodeficiency virus type 1 isolates in vivo.赋予齐多夫定和去羟肌苷耐药性且在体外具有不同效应的pol突变,在体内产生多重耐药的1型人类免疫缺陷病毒分离株。
Antimicrob Agents Chemother. 1993 Jul;37(7):1480-7. doi: 10.1128/AAC.37.7.1480.
10
An in vivo mutation from leucine to tryptophan at position 210 in human immunodeficiency virus type 1 reverse transcriptase contributes to high-level resistance to 3'-azido-3'-deoxythymidine.人类免疫缺陷病毒1型逆转录酶第210位的亮氨酸在体内突变为色氨酸会导致对3'-叠氮-3'-脱氧胸苷产生高水平耐药性。
J Virol. 1996 Nov;70(11):8010-8. doi: 10.1128/JVI.70.11.8010-8018.1996.